Ravi Sachdev

Partner

CD&R

Joined: 2015

Office Phone:

(212) 407-5200


  Pro - Try 1 Week Free
 

    and access,

  •     75K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     194K Transactions
  •     198K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Mr. Sachdev joined CD&R in 2015. He plays a key role in the Firm’s investments in agilon health, Vets First Choice, Tranzact and Healogics. Previously, he served as a Managing Director and Co-Head of Healthcare Services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant and the IPOs of HealthEquity, SCA, Premier and IMS Health. He received his B.A. in economics from the University of Michigan.

Education

University of Michigan , Michigan,
1 of 114

Work History

J.P. Morgan & Co. Inc.

Deutsche Bank AG

Solomon Partners